Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Lung & Bronchus (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 34.3 (34.2, 34.4) N/A 140,561 64.9
Kentucky 3 57.7 (56.9, 58.6) 1 (1, 1) 3,392 68.5
West Virginia 6 52.0 (50.8, 53.3) 2 (2, 2) 1,405 68.0
Mississippi 6 46.6 (45.6, 47.6) 3 (3, 4) 1,759 67.8
Maine 6 44.4 (43.1, 45.7) 4 (3, 8) 947 65.7
Missouri 6 43.9 (43.2, 44.5) 5 (4, 8) 3,570 65.3
Louisiana 3 43.8 (43.0, 44.6) 6 (4, 8) 2,540 72.1
Tennessee 6 43.5 (42.9, 44.2) 7 (4, 8) 3,882 64.2
Arkansas 6 42.7 (41.7, 43.6) 8 (5, 11) 1,690 62.6
Iowa 3 42.0 (41.2, 43.0) 9 (7, 12) 1,766 69.2
North Carolina 6 42.0 (41.5, 42.5) 10 (8, 11) 5,597 67.3
Ohio 6 41.9 (41.5, 42.4) 11 (8, 11) 6,615 65.4
Oklahoma 6 40.5 (39.7, 41.3) 12 (11, 13) 1,976 64.3
Michigan 6 39.5 (39.0, 40.0) 13 (12, 15) 5,396 67.3
Georgia 3 38.9 (38.4, 39.4) 14 (13, 16) 4,758 69.2
Illinois 3 38.4 (37.9, 38.8) 15 (14, 17) 6,143 66.1
New Hampshire 6 38.1 (36.8, 39.4) 16 (13, 22) 756 64.6
South Carolina 6 37.6 (37.0, 38.3) 17 (15, 21) 2,630 64.7
Pennsylvania 6 37.5 (37.1, 37.9) 18 (16, 21) 6,864 64.8
Wisconsin 6 36.9 (36.3, 37.5) 19 (17, 23) 2,920 66.4
North Dakota 6 36.7 (34.9, 38.5) 20 (14, 29) 336 65.5
South Dakota 6 36.5 (34.9, 38.2) 21 (14, 29) 414 66.8
Delaware 6 35.9 (34.4, 37.3) 22 (17, 30) 512 64.2
Rhode Island 6 35.7 (34.3, 37.1) 23 (17, 30) 526 59.3
Alabama 6 35.2 (34.6, 35.9) 24 (21, 29) 2,359 60.6
Vermont 6 34.7 (33.0, 36.5) 25 (19, 34) 332 64.1
Connecticut 3 34.7 (34.0, 35.5) 26 (22, 30) 1,687 63.0
Florida 6 34.6 (34.3, 34.9) 27 (23, 30) 11,291 63.3
Kansas 6 34.6 (33.7, 35.5) 28 (22, 31) 1,262 66.5
Alaska 6 34.4 (32.4, 36.5) 29 (18, 36) 253 66.2
New York 3 33.5 (33.2, 33.8) 31 (28, 33) 8,734 62.7
Virginia 6 33.1 (32.6, 33.6) 32 (30, 34) 3,535 64.7
Minnesota 6 32.8 (32.2, 33.4) 33 (30, 35) 2,351 60.6
Nebraska 6 32.4 (31.3, 33.4) 34 (30, 38) 777 62.1
New Jersey 3 31.9 (31.4, 32.4) 35 (33, 37) 3,781 65.1
Maryland 6 31.8 (31.2, 32.4) 36 (33, 38) 2,455 64.1
Washington 5 31.4 (30.9, 32.0) 37 (34, 38) 2,914 64.6
Idaho 3 30.6 (29.5, 31.6) 38 (34, 41) 675 68.1
Oregon 6 29.6 (28.9, 30.2) 39 (38, 42) 1,681 62.2
Texas 3 29.4 (29.2, 29.7) 40 (38, 42) 8,730 64.6
Montana 6 28.8 (27.6, 30.1) 41 (38, 43) 447 62.8
Hawaii 3 28.5 (27.4, 29.6) 42 (39, 43) 578 71.5
District of Columbia 6 26.7 (25.0, 28.6) 43 (41, 47) 179 59.9
Nevada 6 26.0 (25.2, 26.7) 44 (43, 46) 984 59.1
Arizona 6 25.4 (24.9, 25.9) 45 (43, 46) 2,412 60.1
Wyoming 6 24.9 (23.3, 26.6) 46 (43, 48) 185 63.4
California 3 24.5 (24.3, 24.7) 47 (46, 47) 11,010 67.1
Colorado 6 23.3 (22.7, 23.8) 48 (47, 48) 1,505 62.5
New Mexico 3 19.5 (18.8, 20.3) 49 (49, 49) 554 60.1
Utah 3 17.0 (16.4, 17.7) 50 (50, 50) 492 69.0
Puerto Rico 6 7.5 (7.2, 7.9) N/A 342 49.2
Indiana 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/07/2024 9:17 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top